Introduction

Abbreviations 1
Bile acids play an important physiological role in the elimination of cholesterol from the human body since they represent the main degradation pathway for this poorly soluble lipid. Moreover, their emulsifying properties are essential for digestion of dietary fat and lipophilic vitamins. In the last decade, bile acids were additionally discovered to be natural ligands of the farnesoid X receptor (FXR) [1] [2] [3] , a nuclear transcription factor through which they regulate their own biosynthesis via a negative feedback. Moreover, it is now well established that FXR activation by bile acids results in the regulation of various genes involved not solely in bile acid homeostasis but also in cholesterol, triglyceride and glucose metabolism [4] [5] [6] [7] [8] [9] . Therefore, bile acids have gained much attention since they might be of interest as biomarkers or as pharmacological targets in several intestinal and metabolic conditions ranging from Crohn's disease to metabolic syndrome [5, [10] [11] [12] .
Biosynthesis of bile acids mainly takes place in the liver. Oxidation of the cholesterol steroid core by the microsomal cholesterol 7α-hydroxylase (CYP7A1) in the classical pathway represents the rate-limiting step in bile acid biosynthesis and leads to the formation of the precursor 7α-hydroxycholesterol. The final products of the enzymatic cascade are the two primary bile acids cholic acid and chenodeoxycholic acid, which are conjugated to an amino acid, usually glycine or taurine, prior to excretion. Once they are in the intestine, a fraction of conjugated cholic acid and chenodeoxycholic acid are deconjugated and/or converted to secondary bile acids by intestinal bacteria.
The mixture of primary and secondary bile acids formed in this way is reabsorbed 1 C4, 7alpha-hydroxy-4-cholesten-3-one; CA, cholic acid; CDCA, chenodeoxycholic acid; CYP7A1, cholesterol 7α-hydroxylase; DCA, deoxycholic acid; ESI, electrospray ionisation; FDA, Food and Drug Administration; FXR, farnesoid X receptor; GCA, glycocholic acid; GCDCA, glycochenodeoxycholic acid; GDCA, glycodeoxycholic acid; GLCA, glycolithocholic acid; GUDCA, glycoursodeoxycholic acid; LCA, lithocholic acid; LC-MS/MS, liquid chromatography-tandem mass spectrometry; LOQ, limit of quantification; QC, quality control; SPE, solid-phase extraction; TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; TLCA, taurolithocholic acid; TUDCA, tauroursodeoxycholic acid; UDCA, ursodeoxycholic acid from the small intestine and returns to the liver via the portal system in order to be recycled and secreted again into the bile, thus completing the enterohepatic circulation [5] . The bile acid pool of an organism subsequently contains twenty or more different species varying in their abilities to activate FXR, in their susceptibilities to be metabolised by the intestinal bacteria flora and in their half-lives in the enterohepatic circulation. In order to have a better overview on the amount of newly synthesised bile acids out of cholesterol (in contrast to bile acids found in the circulation after reabsorption from the intestine), quantification of a bile acid precursor may be used. In this regard, it was shown that plasma levels of 7α-hydroxycholesterol, the precursor for the classical pathway, reflect bile acid synthesis in vivo [13] . However, this steroid may be formed from cholesterol as an artefact due to lipid peroxidation and therefore a sample might contain undefined amounts of 7α-hydroxycholesterol of non-enzymatic origin 7α-hydroxy-4-cholesten-3-one (C4), the immediate enzymatic product of 7α-hydroxycholesterol is not formed by lipid peroxidation and was shown to reflect the activity of CYP7A1 in humans as well.
Therefore, it can also be used as a marker for bile acid biosynthesis [14] [15] .
Because of the complexity of this class of compounds and their low concentration in the peripheral circulation as a result of efficient first-pass extraction by the liver, quantification of bile acids requires analytical techniques which offer high sensitivity and specificity. Moreover, due to the broad spectrum of activation potencies of the various bile acids on FXR, differentiated quantification of these metabolites is needed in order to understand the molecular mechanisms in which bile acids are involved.
This was achieved as chromatographic techniques were coupled to mass spectrometry and has led to the expansion of this field of research. In contrast to gas chromatography, which requires laborious sample preparation including hydrolysis and derivatisation, liquid chromatography coupled with mass spectrometry (LC-MS(/MS)) nowadays represents the most convenient alternative for this type of analysis, as demonstrated by the number of new quantification methods developed in the past years for bile acids [16] [17] [18] [19] [20] [21] [22] [23] [24] and C4 [12, 14, [25] [26] .
In this paper, we present two new LC-MS/MS methods for the combined quantification in serum of the 15 major human bile acids on one hand and their precursor for the classical pathway, namely C4, on the other (Figure 1 ). The main assets of these methods are that they require low sample volume (100μl for each method) and that they enable a detailed description of bile acid metabolism since they provide information not only on the composition of the circulating bile acid pool but also on the amount of newly synthesised bile acids via C4 quantification.
Moreover, these methods can be combined since they require identical eluents for the mobile phase, an identical stationary phase and the same ionisation technique.
This simplifies the procedure and spares hardware modifications because neither the column nor the source needs to be changed between different types of samples.
Together with another method previously developed in our group for the quantification of the bile acid precursor for the alternative biosynthesis pathway, namely 27-hydroxycholesterol [27] , these tools allow a detailed description of bile acid metabolism in humans.
Experimental
Chemicals
Cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA), ursodeoxycholic acid (UDCA), glycochenodeoxycholic acid (GCDCA), glycodeoxycholic acid (GDCA), taurochenodeoxycholic acid (TCDCA) and taurodeoxycholic acid (TDCA) were purchased from Sigma-Aldrich (Buchs, Switzerland), whereas the glycine-and taurine-conjugates of CA (GCA and TCA), LCA (GLCA and TLCA) and UDCA (GUDCA and TUDCA) were obtained from Calbiochem (Darmstadt, Germany). The deuterated bile acid internal standards 
Preparation of a bile acid/C4-free serum pool
In order to construct calibration curves in a matrix free from endogenous bile acids and C4 but similar to the real sample matrix, serum was mixed overnight with 100mg/ml activated charcoal, known for its high adsorption capacity. The mixture was then centrifuged at 13'000 x g and 10°C for 20min, after which the supernatant was collected and centrifuged again. After three centrifugation cycles, the supernatant was filtered with a 0.45μm filter and stored at -20°C until analysis. Prior to use, newly prepared charcoal treated serum batches were tested for the absence of any remaining endogenous bile acids or C4 (data not shown).
Preparation of standard stock solutions
Bile acid standard stock solutions were prepared by dissolving the respective 15 bile acids in the appropriate amount of methanol in order to obtain individual stock solutions of 5μmol/ml. The 15 individual stock solutions were then pooled together to obtain a 100μmol/l solution in methanol, which was further diluted with purified water to obtain standard stock solutions containing 25, 10, 5, 0.5 and 0.05μmol/l of each bile acid, respectively.
A 1μmol/ml C4 standard stock solution was prepared by dissolving C4 in the appropriate amount of acetonitrile. This solution was further diluted with methanol to obtain 0.5, 0.1, 0.05 and 0.01μmol/l standard stock solutions.
Preparation of deuterated internal standard stock solutions
The 7 deuterated bile acids were dissolved in the appropriate amount of methanol in order to obtain individual 3μmol/ml solutions. These solutions were then pooled together to obtain a 75μmol/l solution in methanol, which was further diluted with water to obtain an internal standard solution containing 15μmol/l of each deuterated bile acid.
A 1μmol/ml C4-d 7 solution was prepared in acetonitrile and further diluted with methanol to obtain a 0.1μmol/l C4-d 7 internal standard solution.
Sample preparation
Calibrators and quality control samples (QCs) were prepared by adding the appropriate amount of the different standard stock solutions to 100μl of charcoal treated serum and extracting these using the corresponding sample preparation procedure described below.
Sample preparation for the 15 bile acids
100μl serum sample (respectively 100μl charcoal treated serum with defined amounts of the appropriate standard stock solution) were mixed with 100μl ammonium carbonate buffer 100mM, pH 9.3. The volume was completed to 700μl with purified water and 30μl of the 15μmol/l deuterated bile acids internal standard solution were added, after which the samples were vortexed.
Sample preparation was performed by solid-phase extraction (SPE) with 200mg
Bond Elut C18 cartridges from Varian, Inc. (Palo Alto, CA, USA) using a procedure previously described by our group [24] , after minor adaptations (mainly reduction of sample volume). Pre-conditioning of the cartridges was achieved by activation with 2ml methanol followed by 2ml purified water and finally 2ml ammonium carbonate buffer 100mM, pH 9.3, upon which the sample was loaded onto the cartridge and allowed to pass through it by gravity. Thereafter, the cartridge was washed with 2ml purified water and dried under vacuum. The retained compounds were eluted with 3ml of methanol using gravity and the samples were evaporated at 30°C under vacuum using a rotavapor from Büchi (Flawil, Switzerland). The residue was dissolved in 60μl methanol and mixed with 30μl ammonium acetate buffer 10mM, pH 6.5, upon which the sample was centrifuged at 13'400 x g and 10°C for 10min. The supernatant was collected and 30μl were injected into the LC-MS system for analysis.
Sample preparation for C4
100μl serum sample (respectively 100μl charcoal treated serum with defined amounts of the appropriate standard stock solution) were mixed with 500μl purified water and 50μl of the 0.1μmol/l C4-d 7 internal standard solution. The methanol volume (including 50μl internal standard solution and various amounts of standard stock solutions) was completed to 150μl in all samples in order to avoid variations due to different methanol contents while loading the samples on the SPE cartridges.
Finally, 60μl of 1M hydrochloric acid were added to all samples and these were vortexed immediately afterwards in order to loosen the C4 fraction presumably bound to plasma proteins.
Sample preparation was performed using the same solid-phase extraction cartridges as for the bile acids sample preparation. Pre-conditioning of the cartridges was achieved by activation with 2ml methanol followed by 2ml purified water, upon which the sample was loaded onto the cartridge and allowed to pass through it by gravity.
The cartridge was washed and samples were eluted and evaporated as described in the bile acid sample preparation procedure (2.5.1). The residue was dissolved in 80μl methanol and mixed with 10μl ammonium acetate buffer 10mM, pH 6.5, upon which the sample was centrifuged at 13'400 x g and 10°C for 10min. The supernatant was collected and 30μl were injected into the LC-MS system for analysis.
Quantification
The calibration domain for the 15 bile acids ranged from 0.02μmol/l to 50μmol/l and could be extended to 100μmol/l without affecting linearity by adding two additional calibrators if required (for highly concentrated samples). Due to the large calibration range, the intercept contributed significantly to the peak area ratios of low concentrated samples. Therefore samples with concentrations above 5μmol/l were calculated using all 6 (respectively 8) calibrators 0.02, 0.5, 5, 10, 30 and 50μmol/l (respectively 75 and 100μmol/l), whereas samples with concentrations below 5μmol/l were calculated using only the first 3 calibrators. Samples with concentrations below 0.02μmol/l as well as samples for which the peak area ratio was below the absolute value of the intercept of its respective 3 points calibration curve were calculated by proportional conversion using the respective peak area ratio of the first calibration standard. Since deuterated internal standards with identical structure were not commercially available for each of the 15 bile acids at the time the method was developed, those lacking an identical deuterated homologue were attributed the corresponding unconjugated deuterated bile acid (Table 1) . Although the deuterated bile acids used as internal standards were of high purity, they contained a fraction of corresponding undeuterated bile acid which contributed to the peak area of the analytes in the samples as well as in the calibrators and the QCs. The percentage of undeuterated bile acids contained in the various internal standards varied from 0.1% to 1.2% and this effect was corrected by subtracting a defined percentage of the internal standard peak from the corresponding undeuterated analyte peak in every analysis.
The calibration domain for C4 ranged from 0.01μmol/l to 0.4μmol/l and sample concentration was calculated similarly as described above. Samples with concentrations above 0.05μmol/l were calculated using all 6 calibrators 0.01, 0.02, 0.05, 0.1, 0.2 and 0.4μmol/l, whereas samples with concentrations below 0.05μmol/l were calculated using only the 3 first calibrators. Samples with concentrations below 0.01μmol/l as well as samples for which the peak area ratio was below the absolute value of the intercept of its respective 3 points calibration curve were calculated by proportional conversion using the respective peak area ratio of the first calibration standard. Since only insignificant amounts of undeuterated C4 impurity could be detected in the C4-d 7 internal standard solution, the peak area of C4 did not need to be corrected in contrast to that of bile acids.
Instrumentation
The LC-MS system consisted of an HTC PAL autosampler from CTC Analytics (Zwingen, Switzerland) coupled with a Rheos 2200 HPLC pump from Flux Instruments (Reinach, Switzerland) and a TSQ Quantum Access mass spectrometer from Thermo Scientific (Waltham, MA, USA). Separation was achieved using a 125mm x 2.0mm Uptisphere C 18 5μm particle size ODB column from Interchim (Montluçon, France), which was protected by a 10mm x 2.0mm modulo-cart QS guard column also from Interchim. Data acquisition was performed using Xcalibur software (version 2.0.6) from Thermo Scientific.
Separation, ionisation and detection conditions
Mobile phase for both methods consisted of methanol (eluent A) and 10mM ammonium acetate buffer at pH 6.5 (eluent B).
For separation of the bile acids, the eluents were set to 65% A and 35% B during the first 10min, after which the proportions were changed within 2min to 70% A and 30% B and maintained for 4min. After 16min of analysis, the proportions were changed again within 1min to 80% A and 20% B and maintained for 8min. At 25min, the proportions were changed to 100% A and maintained for 5min in order to flush the column, upon which the conditions were set to the beginning proportions of 65% A and 35% B for 20min to equilibrate the chromatographic column. The flow rate was set to 300μl/min during the whole analysis.
The separation of the more hydrophobic C4 was achieved with a mobile phase containing 93% A and 7% B at a flow rate of 250μl/min. After 10min the column was flushed for 5min with 400μl/min of eluent A and finally the column was equilibrated for 10min at a flow rate of 300μl/min with the beginning proportions of 93% A and 7% B.
In both methods, ionisation was performed using an electrospray ionisation (ESI) source, which was operating in the negative mode for bile acids and in the positive mode for C4. Ionisation parameters were tuned for the different compounds and optimal conditions are shown in Table 2 . The tube lens and collision energy values were individually optimised for each analyte and are reported in Table 1 . Collision pressure was set to the default value of 1.5mTorr. Scan time was set to 0.05s for the bile acids and to 0.5s for C4, while scan width was set to 0.002m/z for both methods.
Due to the lack of stable fragments for unconjugated bile acids, their detection was performed in the pseudo-selected reaction monitoring mode. This detection mode uses low collision energy, which does not fragment the parent ion, but decreases the background noise and therefore leads to a better signal-to-noise ratio. In contrast, all of the conjugated bile acids as well as C4 showed reproducible fragments which are reported in Table 1 .
Method validation
A detailed validation procedure was performed according to the Food and Drug Administration (FDA) guidelines [28].
Linearity
Defined amounts of standard stock solutions were added to charcoal treated serum for preparation of 6 calibration points ranging from 0.02μmol/l to 50μmol/l for bile acids and from 0.01μmol/l to 0.4μmol/l for C4. The samples were extracted as described in paragraph 2.5.1 and 2.5.2 respectively. Calibration curves were plotted as the peak area ratio of the respective bile acid over its internal standard against the nominal concentration of the calibrator. The line of best fit was determined by least square linear regression for the lower calibration domain (3 lowest calibrators) as well as for the entire calibration domain for both methods and for six freshly prepared calibration curves. Calculation of the mean correlation coefficient was used to assess linearity.
Precision and accuracy
In order to assess intra-day precision and accuracy, six QCs of a low and of a high concentration (0.5μmol/l and 30μmol/l for bile acids versus 0.02μmol/l and 0.2μmol/l for C4) were extracted and analysed using a freshly prepared calibration curve on a given day. Additional QCs for each the low and the high concentrations were also analysed on five different days, each time with a freshly prepared calibration curve, in order to assess inter-day precision and accuracy. Precision of the method was represented by the coefficient of variation while accuracy was obtained by expressing the mean of the measured concentrations as a percentage of the nominal concentration.
Recovery
Since matrix constituents are known to influence the extraction process, the recovery experiment was performed using untreated serum instead of a charcoal treated serum in order to have extraction conditions as close as possible to those of real samples.
In order to assess efficiency of the extraction procedure, twelve serum samples were extracted for each a low and a high concentration (0.5μmol/l and 30μmol/l for bile acids versus 0.02μmol/l and 0.2μmol/l for C4). From these twelve samples, six were spiked with the appropriate amount of standard stock solutions and internal standards before extraction. The six remaining samples were extracted as blanks and spiked with the same amount of standard stock solutions and internal standards after the extraction. Six additional blank samples containing only endogenous bile acids or C4 were extracted without addition of any standard stock solutions or internal standards. Thereafter all samples were evaporated and dissolved in mobile phase according to 2.5.1 and 2.5.2 respectively. After correction of the spiked serum samples by subtraction of endogenous amounts of the respective analyte, recovery was obtained by expressing the mean peak area of samples spiked before extraction as a percentage of that of samples spiked after extraction.
Limit of quantification
QCs were spiked with concentrations ranging from 0.002μmol/l to 0.05μmol/l for the bile acids and 0.001μmol/l to 0.01μmol/l for C4. Five replicates were extracted and analysed for each concentration and limit of quantification (LOQ) was determined as being the lowest concentration at which the analyte could be quantified with sufficient precision and accuracy.
Matrix effects
Matrix effects were assessed by two different methods, in both a quantitative and a qualitative manner. Because of the major role played by matrix components, these experiments were performed using untreated serum instead of charcoal treated serum.
In order to assess matrix effects in a quantitative manner, six blank serum samples were extracted using the procedures described for bile acids and C4 respectively.
After extraction, three samples were spiked with defined amounts of standard stock solutions (10μmol/l for bile acids versus 0.1μmol/l for C4) and internal standards, while the remaining three samples were kept as blank samples. Simultaneously, identical amounts of standard stock solutions and internal standards were pipetted into three clean vials. All samples were then evaporated and dissolved in mobile 
Results and discussion
Preparation of standard stock solutions
During method development, a rapid decrease in peak intensity was observed in aqueous solutions of C4 (data not shown). This decrease was probably due to poor aqueous solubility of C4 because it was not observed when C4 was dissolved in methanol. Therefore all C4 standard stock solutions were prepared in methanol, although this should be avoided as much as possible when using solid-phase extraction. Nevertheless, in order to have identical extraction conditions, the methanol volume was completed to 150μl in all C4 samples. In contrast to C4, bile acids were dissolved in water and showed no decrease in peak intensity.
Sample preparation
Our new methods each required only 100μl of serum sample, which was less than for many of the existing methods [12, 14, 16, 20, [22] [23] [24] although methods for quantification of C4 in even smaller sample volumes exist [25] [26] . A low sample volume represents an important advantage if the method is to be adapted for analysis of mouse samples (muricholic acids), since mice have a very small blood volume. In addition, our C4 method offers the advantage of requiring a rather short sample preparation in comparison to other existing methods [14, [25] [26] and no derivatization [25] [26] . However, in order for these methods to be improved, efforts should be made to find a combined extraction procedure for bile acids and C4, which would reduce sample volume to only 100μl instead of twice 100μl and would lead to a shorter total analysis time. This was not achieved yet since C4 seems to be bound to plasma proteins and required the addition of hydrochloric acid in order to obtain sufficient recovery, which in turn would probably hydrolyse the gylcine and taurine moieties of conjugated species if the same procedure was applied to bile acids.
Separation, ionisation and detection conditions
The baseline separation of the two isomers CDCA and DCA as well as their glycineand taurine-conjugates represented the main limitation for the chromatographic separation of the 15 bile acids since these isomers behave identically with respect to fragmentation and therefore they cannot be distinguished from each other by mass spectrometry only. Separation of the 15 major bile acids was consequently achieved in 20min. In the case of C4, the peak retention time was delayed to approximately 8min because it needed to be separated from a 100 times more intense co-eluting peak of unknown origin in order to minimise ion suppression effects (data not shown).
Selectivity is undeniably lower for unconjugated bile acids due to the absence of reproducible fragments, which was also the case in previously developed LC-MS methods for bile acids. However, the relevance of this analytical limitation depends on the context of the intended application.
Examples of mass chromatograms of bile acids and C4 in serum from a healthy volunteer is shown in Figure 2 . The total bile acid concentration in this serum reached 5.0μmol/l with GCDCA being the most concentrated species (1.4μmol/l), while the concentration obtained for C4 was 24.5nmol/l. ESI was chosen for the ionisation of bile acids since these molecules possess a carboxyl group (unconjugated and glycine-conjugated bile acids) or a sulfonyl group (taurine-conjugated bile acids) which easily generates negatively charged ions in solution. Ionisation of C4 was also performed using ESI although atmospheric pressure chemical ionisation (APCI) would probably have been a better suited ionisation technique regarding the polarity of the analyte. Nevertheless, ESI was preferred because it offered the possibility of combined application of both methods in addition to a sufficient sensitivity for the analysis of C4. The combined application of both methods represents an advantage, particularly for the analysis of large batches of samples. Indeed, the fact that both methods require the same eluents, stationary phase and ionisation source allows to run sequences containing both types of samples without any modifications of hardware (column, source), thereby sparing time and reducing the risk of handling errors.
Method validation
Linearity
The calibration curves were linear in both calibration ranges for the 15 bile acids and C4. For the bile acids, the mean correlation coefficients r (n = 6) ranged from 0.9983 to 1.0000 for the lower calibration domain (0.02-5μmol/l) and from 0.9994 to 1.0000 for the entire calibration domain (0.02-50μmol/l). Linearity was also observed if the calibration domain was extended to 100μmol/l for high concentrated samples (data not shown). For C4, the mean correlation coefficient r (n = 6) was 0.9993 for both the lower (0.01-0.05μmol/l) and the entire (0.01-0.4μmol/l) calibration domain.
Precision and accuracy
Intra-and inter-day precision and accuracy data are summarized in Table 3 . For bile acids, intra-day (inter-day) variation (n = 6) ranged from 0.3% to 4.8% (0.7% to 11.9%). Intra-day (inter-day) accuracy (n = 6) ranged from 87.6% to 102% (84.7% to 102%). For C4, intra-day (inter-day) variation (n = 6) was below or equal to 5.2% (3.6%). Intra-day (inter-day) accuracy (n = 6) was 89.1% and 98.4% (97.7% and 98.3%) for the low and the high QCs respectively. The precision and accuracy data were within the interval set by the FDA concerning validation of bioanalytical methods
[28].
Recovery
The extraction recoveries (n = 6) of the different bile acids and C4 are shown in Table   3 . This experiment only took in account the efficiency of the extraction procedure per se and not the matrix effects which are discussed below. In this case, matrix effects were identical for all samples since serum samples spiked before extraction were compared to serum samples spiked after extraction.
The extraction recoveries for bile acids ranged from 78.3% to 99.3% and were slightly higher for 30μmol/l than for 0.5μmol/l samples, which might be due to imprecision in low concentrated samples when correcting for endogenous amounts, since error is proportionally higher on low concentrations. However, this did not affect linearity as demonstrated in 3.4.1. Table 4 summarizes and compares extraction recoveries of the here and previously reported methods for the measurement of bile acids and C4. Extraction recoveries for bile acids were quite similar to those reported for other existing methods [16] [17] [18] 20, [22] [23] [24] . The extraction recovery for C4 was found to be approximately 62%, which was markedly lower than for bile acids and for other C4 methods [12, 14, [25] [26] . This is presumably explained by its lipophilic properties and by the fact that the others methods used different sample preparation techniques (protein precipitation, liquid-liquid extraction followed by SPE, derivatisation and salting-out respectively).
Limit of quantification
LOQ was defined as the lowest concentration at which the analyte could be quantified with a coefficient of variation below 20% and accuracy between 80% and 120% (n = 5). For bile acids, LOQ ranged from 2nmol/l to 50nmol/l. After correction for sample volume, this was comparable or slightly better than what has been reported in recent publications providing LOQ values [16, [18] [19] [20] [23] [24] (Table 4 ). For C4, LOQ was 5nmol/l, which is similar to what was reported by DeBarber et al. [25] .
The detailed LOQ values for the individual analytes are shown in Table 5 .
Matrix effects
The results of the quantitative matrix effects test (n = 3) are shown in Table 6 . In contrast to recovery, this experiment takes into account only the matrix effects (and not the loss that occurs during extraction) since the analytes were added to the matrix after extraction and compared to the same amount of analytes in pure solvents.
The signal in presence of matrix components was between 73% and 103% of the signal in pure standards for all analytes, which indicated some competition between the analytes and interfering matrix components during ionisation. However, assessment of matrix effects in a qualitative way with post-column infusion of the analytes showed no significant ion suppression or enhancement effects in relevant detection timeframes, as demonstrated in Figure 3 .
In this paper, recovery and matrix effects were evaluated in separate experiments (2.9.3 and 2.9.5) unlike in some publications where recovery is assessed by comparing an extracted spiked sample to a stock solution. In this latter case, it would not be clear whether a decrease in signal intensity is due to insufficient extraction recovery or to ion suppression.
Quantification of bile acids and C4 in a patient with cirrhosis and cholestasis
As an application example, bile acids and C4 were quantified in the serum of a 39-year old woman suffering from liver cirrhosis and cholecystolithiasis (gallstones) among other conditions (Figure 4) . Clinical findings showed increased levels of total bilirubin (32μmol/l), gamma-glutamyl transferase (356U/l) and alkaline phosphatase (189U/l), which indicate the presence of cholestasis and liver damage. The total bile acid concentration in this patient was 10 times higher than in the serum from a healthy volunteer displayed in Figure 2 (56.5μmol/l versus 5.0μmol/l), which is often observed in cholestatic conditions. While glycine and taurine conjugates of the primary bile acids (GCA, GCDCA, TCA and TCDCA) showed up to an 80-fold increase in concentration compared to serum from a healthy volunteer, all secondary bile acids except GUDCA had concentrations below LOQ. Several of them (GDCA, TDCA and TLCA) were totally absent from the circulation as a consequence of breakdown of enterohepatic circulation. The concentration obtained for C4 was 1.2nmol/l, (<LOQ) and indicates poor liver function due to cirrhosis, as C4 concentrations in healthy subjects have been reported to be between 12nmol/l and 120nmol/l (5-48ng/ml) [14] .
Conclusions
In addition to their traditionally recognized role in lipid emulsification, bile acids were found to be biologically important signaling molecules, which has resulted in an increased relevance of these metabolites in biology and medicine and in a greater demand for sensitive, precise and accurate methods for the quantification of bile acids in recent years.
In this paper, we described two new methods based on LC-MS/MS for the combined quantification of the 15 major human bile acids and their precursor for the classical biosynthesis pathway, namely C4, in serum. The advantage of these methods lies in their ability to describe both the composition of the circulating bile acid pool and the amount of newly synthesised bile acids, reflected by C4 concentrations. Combination of both methods is possible since the eluents for the mobile phase, the stationary phase as well as the ionisation source are identical. These new methods allow detailed insight into bile acid metabolism in humans, which will provide additional valuable information while performing clinical studies to determine the prognostic and/or diagnostic value of cholesterol metabolites in various diseases. The total bile acid concentration represented 56.5μmol/l, whereas the C4 concentration was 1.2nmol/l (<LOQ).
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Table 1
Parent and product ions of the analytes with individually optimised detection parameters (tube lens and collision energy) as well as corresponding internal standard used for quantification. If more than one fragment was reported, the sum of the signals of the different product ions was used for quantification. 
